FDA Approves Genentech's Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple SclerosisBusiness Wire • 12/14/20
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patientsGlobeNewsWire • 12/11/20
Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020GlobeNewsWire • 12/10/20
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trialsGlobeNewsWire • 12/09/20
Roche presents new data from its bispecific antibody portfolio across a range of blood cancersGlobeNewsWire • 12/08/20
New data presented at ASH 2020 reinforces the benefit/risk profile of fixed-duration Polivy plus bendamustine and MabThera/Rituxan in patients with relapsed or refractory diffuse large B-cell lymphomaGlobeNewsWire • 12/07/20
New follow-up phase III data reinforce the long-term benefit of Roche's Hemlibra for people with haemophilia AGlobeNewsWire • 12/07/20
Roche announces new data reinforcing the long-term benefit of Venclexta/Venclyxto-based combination for people with relapsed or refractory chronic lymphocytic leukaemiaGlobeNewsWire • 12/05/20
Genentech Announces New Data Reinforcing the Long-Term Benefit of Venclexta-Based Combination for People With Relapsed or Refractory Chronic Lymphocytic LeukemiaBusiness Wire • 12/05/20
Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancersGlobeNewsWire • 12/02/20
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodiesGlobeNewsWire • 12/02/20
Genentech Announces FDA Approval of Gavreto (pralsetinib) for People With Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid CancersBusiness Wire • 12/01/20
Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal PolypsBusiness Wire • 12/01/20
Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodiesPRNewsWire • 12/01/20
Analog Devices, Inc. (ADI) CEO Vincent Roche on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/24/20